Page 511 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice
P. 511

Fluid, Electrolyte, and Acid-Base Disturbances in Liver Disease  499



            236. Wong F, Liu P, Blendis L. The mechanism of improved  receptor antagonist, on vasopressin-induced cardiac and
                sodium homeostasis of low-dose losartan in preascitic cir-  haemodynamic  changes  in  anaesthetised  dogs.
                rhosis. Hepatology 2002;35:1449–58.                  Pharamacol Res 2002;46:375–81.
            237. Woods HF, Connor H, Tucker GT. The role of altered lac-  241. Yedgar S, Carew RE, Pittman RC, et al. Tissue sites of
                tate kinetics in the pathogenesis of type B lactic acidosis.  catabolism of albumin in rabbits. Am J Physiol
                In: Porter R, editor. Metabolic acidosis, CIBA Found  1983;244:E101–E107.
                Symp 87; 1982:. p. 307–23.                      242. Zavagli G, Ricci G, Bader G, et al. The importance of the
            238. Yacobi A, Gibson TP, McEntegart CM, et al. Pharmaco-  highest normokalemia in the treatment of early hepatic
                kinetics of high molecular weight hydroxyethyl starch in  encephalopathy.  Miner  Electrolyte  Metab
                dogs.  Res  Comm    Chem    Pathol  Pharmacol        1993;19:362–7.
                1982;36:199–204.                                243. Zimmon DS, Oratz M, Kessler R, et al. Albumin to asci-
            239. Yang YY, Lin HC, Lee WC, et al. One-week losartan   tes. Demonstration of a direct pathway bypassing the sys-
                administration increases sodium excretion in cirrhotic  temic circulation. J Clin Invest 1969;48:2074–8.
                patients with and without ascites. J Gastroenterol  244. Zoran DL, Jergens AE, Riedesel DH, et al. Evaluation of
                2002;37:194–9.                                       hemostatic analytes after use of hypertonic saline solution
            240. Yatsu T, Kusayama T, Tomura Y, et al. Effect of     combined with colloids for resuscitation of dogs with
                conivaptan, a combined vasopressin V(1a) and V(2)    hypovolemia. Am J Vet Res 1992;53:1791–6.
   506   507   508   509   510   511   512   513   514   515   516